µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º
y?[ v=j*U
Sz%tJD..
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ mC4zactv
9A/\h3HrJ
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) `>7;!
iQ tNAj
1. ICAM-1 j-4VB_N@
T}Km?d
2. interleukin 12(IL-12) _D+}q_
%7"q"A r[
3. tumor infiltrating lymphocyte 8|):`u
w,.+IV$Kk
4. TCR/CD3 complex Sc>,lIM
q
0$,*[PH
5. hematopoietin receptor family 9i'jjN
J}htu
6. individual idiotype(IdI) [="
e
ziM{
J4QXz[dG
7. integrin "oTHq]Ku
X>d"]GD
8. colony-stimulatory factor (CSF) !Z`j2
e}
/,89p&h
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© )jU)_To
I
CZ4A{I
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? =q>'19^Jx
JI? rL
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ jq-p;-i
W0(_~
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ|
h`0u'#
L;
T8?+ x
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ |S_T^'<W
/mXBvY
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) @PN#p"KaT
IM:=@a{
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ P7J>+cm
{kp-h2I,
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) _.>QEh5"5
3 ,>0a
3. immunoglobulin superfamily (IgSF) * 1T&
\qR7mI/*
4. selectin ?f#y1m
wQv'8A_}
5. anti-idiotypic antibody (¦ÁId) So{x]x:f
'HT7_$?*
6. major histocompatibility complex(MHC) H]Cy=Zi"
LL] zT H0
7. immunotolerance 0FGe=$vD
7bqBk,`9
8. biological reponse modifier(BRM) MJ7 Y#<u
q:l>O5
9. immune reponse gene (Ir gene) z|=}1;(.
=fu
:@+
10. reshaped antibody (or reconstituted antibody) Z= jr-)kK
^9^WuSq
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© el2bd
:
AP
[|Ta
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ 8*8Zc/{
0.dgoq3u
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? W)9K`hM6
] x\-$~E
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ zV:pQRbt.
cj+ FRG~u
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? %{YN70/
$tz;
<M7B
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ "5;;)\o~
M(jgd
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? x\F,SEj
vN|l\!~
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ "
Om[~-31
/TZOJE(2j
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ S>.SSXlM
*:>"q ej
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? )jkXSTZ
m-H-6`]
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ XK|R8rhg8`
A,\6nO67
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: 8<.C3m
6h
0j30LXI_
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: N@O8\oQG
ZKQG:M~|
̉񧄤 cU{e`<xjA
.so[I
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© @O@GRq&V
,$'])A?
$
1. CD8 J9\a{c;.
.k
3'
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) vC1v"L;[o/
,0
E{h}(
3. immunoglobulin fold(Ig fold) P(XaTU&-
4hAl-8~Q6
4. cadherin (Ca-dependent cell adhesion moleculers) p/U+
0f
IkrF/$r
5. idiotype-anti-idiotypic antibody immune network theory :WSDf VX
3t<a $i
6. HLA class II antigen zo[[>MA
1gmt2>#v%
7. complementarity-determining region (CDR) *^RmjW1I
"y_#7K
8. perforin(or pore-forming protein ,PFP) [8Qro8
'Hi:
2Wh
9. high affinity IL-2 receptor :$_6SQ<?
c%[#~;E
10. artificial active immunization
W -
)ZBY* lk9
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© + +aL4:
2*N_5&9mE
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠm}8[
#:
%e`$p=m
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 >[Ye
MY/3]g<
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ +=]!P#
zCOgBT~p
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ p|Q*5TO
lj{VL}R
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ <`jLY)sw
2MATpV#BT
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? {0;3W7
Dk+&X-]6x5
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ {
.*y
@h*fFiY&{
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ "wlt> SU
70lfb`
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ fM #7 y [
PG8^.)]M
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ 4*aZ>R2hO
.<z!3O&L
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© etd&..]J
`;YU.*
1. immunoglobulin gene rearrangement gORJWQv
'kYwz;gp
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) 49d@!
2kv7UU#q2
3. flow cytometry(FCM) vsL[*OeI
* ,v|y6
4. carrier effect /t6X(*xoy
y7S4d~&
5. positive selection of T lymphocytes in thymus d*oUfiW
Q#(GI2F2#
6. mouse TH1(Th1) and TH2(Th2) subsets }|B=h
__[xD\ES
7. perforin (pore-forming protein ,PFP) Fkf97O
i
N)S!7%ne
8. ADCC(antibody-dependent cell-mediated cytotoxicity) <xJ/y|{
^FZ^6*
9. SH-2(src-homology region 2) JbO ~n
)%x
/%A;mlf{
10. Ab2¦Â (internal image) ubu?S%`
9s}Kl($
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© KOg?FmD
\@}#Gez
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? Z?J:$of*
WZ!WxX>zO
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? F?m?UQS'u
hh~n#7w~IR
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠy<XlRTy[}
hF3&i=;.
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ }j1!j&&
=2y8CgLj
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠF8e<}v&7R
$jd<v1"o
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£)
0Q5 93F
M}DH5H"s
ÃâÒßѧרҵ£º _,6f#t
}.)s%4p8
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ u)Q;8$`
f>$h@/-*
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? .BO<
%;z((3F
´«È¾²¡Ñ§×¨Òµ£º ?IX!+>.H
r^HAa GpC
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ /T0nLp`gi
>+cVs:
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ 'ul\Q`N3
2
Tvvq(?T
Ïû»¯×¨Òµ£º lS{r=y_0.
<XQ.A3SG!
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ ++[5q+b
% U`xu.
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? z&nZ<ih
OQlG+|
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ Q^eJ4{Ya:
FE5Q?*Ea
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© Uhh
l3%p
^9"KTZc-*
1. Fas(CD95)/FasL >tRHNB_
00vBpsZj2;
2. common chain of cytokine receptor v:ER4
ce
p$_Ja
3 . TCR/CD3 complex 2BB<mv
K4
yOHXY&
4. negaive selection of thymocytes S0@T0y#
~o15#Pfn/
5. artificial active immune "HQF.#\#
@Gjny BJ
6. anti-idiotypic A[/I#Im7
hCc0sRp
7. IgSF /NBTvTI
4L:>4X[T
8. Integrin E'dX)J9e$/
FRyPeZR
9. chemokine /8 CY0Ey
z: G}>fk5
10. B7/CD28 H7IW"UkBR
a1x7~)z>zi
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© `^8*<+
[e4![G&y`
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ eK_*q-
y lL8+7W
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ J|j;g!fK
Ph)|j&]
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ Di.;<v#FL
6Y?`=kAp
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ %8D?$v"#Z
,YlQK;
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ WN0c%kz=
$%He$t
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ @36S}5Oa
/2w@K_Px6
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© SfDQ;1?
&z ksRX
1. B7/CD28 hWxT !
HDj$"pS
2. Th1 subset ;Q90Y&{L=$
d pn3 (
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© gb_X?j%p7
UPO^V:.R4
4. antibody affinity maturation 5B|,S1b
u\5g3BH
5. AP-1 %BICt @E
Mdm0g
6. single chain variable fragment£¨ScFv£© J0qXtr%h\
%yhI;M^
7. NK cell receptor Lupy:4AD
AA.Ys89V
8. Zinkernagel-Doherty phenomenon q\_DJ)qpn
/&QQ p3
9. Ig fold &%:*\_2s
1gk0l'.z
10. CD40/CD40L U%,;N\:_
@ AggznA8
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© wzbz}P>
@Q3, bj
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ >\&= [C
F`3^wHw^
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ ~K%k
0kT
]'6'<S
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ _ flgQ
Eh
{up
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ 9D%qXU
5U3qr*/ ;m
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ _~:j3=1&